Abiopharma

New Form PRE 14A - PALISADE BIO, INC. Filed: 2025-09-05 AccNo: 0001493152-25-012677 Size: 6 MB

Dizon Romeo R 🟢 acquired 1.1K shares of IRIDEX CORP (IRIX) at $1.39 Transaction Date: Sep 04, 2025 | Filing ID: 113167

New Form 8-K - Lipocine Inc. Filed: 2025-09-05 AccNo: 0001493152-25-012698 Size: 15 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 424B4 - AETHLON MEDICAL INC Filed: 2025-09-05 AccNo: 0001683168-25-006701 Size: 456 KB

Unlock new strategies at HUB25s User Forum sessions

New Form 144 - Aquestive Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0002007317-25-001032 Size: 4 KB

Update on Amgen’s bemarituzumab Phase 3 FORTITUDE-101 Study

Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong

Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer

New Form POS AM - RedHill Biopharma Ltd. Filed: 2025-09-05 AccNo: 0001178913-25-003257 Size: 1 MB

New Form POS AM - RedHill Biopharma Ltd. Filed: 2025-09-05 AccNo: 0001178913-25-003255 Size: 1 MB

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China

New Form 144 - Premier, Inc. Filed: 2025-09-05 AccNo: 0001959173-25-005787 Size: 4 KB

New Form SCHEDULE 13G/A - Forte Biosciences, Inc. Filed: 2025-09-05 AccNo: 0001623632-25-001195 Size: 45 KB

New Form 6-K/A - RedHill Biopharma Ltd. Filed: 2025-09-05 AccNo: 0001558370-25-011890 Size: 2 MB